Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 350 (9075) , 404-407
- https://doi.org/10.1016/s0140-6736(97)07201-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The role of infection in restenosis and atherosclerosis: focus on cytomegalovirusThe Lancet, 1996
- Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseJournal of the American College of Cardiology, 1996
- Intracellular bioactivity of macrolidesClinical Microbiology & Infection, 1996
- Platelet and leukocyte activation after myocardial infarctionEuropean Heart Journal, 1995
- Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factorsBMJ, 1995
- Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.Circulation, 1994
- Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.Circulation, 1993
- Unstable angina. A classification.Circulation, 1989
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Immunological and microbiological factors in the pathogenesis of atherosclerosisClinical Immunology and Immunopathology, 1985